The potential of a multiplex high-throughput molecular assay for early detection of first and second line tuberculosis drug resistance mutations to improve infection control and reduce costs: a decision analytical modeling study

Authored by: van’t Hoog A. H., Bergval I, Tukvadze N, Sengstake S, Aspindzelashvili R, Anthony R. M., Cobelens F.
In: BMC Infectious Diseases, 2015
http://www.ncbi.nlm.nih.gov/pubmed/26503434
http://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-015-1205-4